2019
Gender disparities in head and neck cancer chemotherapy clinical trials participation and treatment
Benchetrit L, Torabi SJ, Tate JP, Mehra S, Osborn HA, Young MR, Burtness B, Judson BL. Gender disparities in head and neck cancer chemotherapy clinical trials participation and treatment. Oral Oncology 2019, 94: 32-40. PMID: 31178210, DOI: 10.1016/j.oraloncology.2019.05.009.Peer-Reviewed Original ResearchConceptsChemotherapy clinical trialsNational Cancer DatabaseClinical trialsDefinitive radiotherapyChemotherapy administrationNational Comprehensive Cancer Network guidelinesMultivariable logistic regression analysisNeck squamous cell carcinomaEnd Results ProgramSquamous cell carcinomaClinical trial participationLogistic regression analysisGeneral U.S. populationChemotherapy useDefinitive chemoradiotherapyNCCN guidelinesAdult patientsDefinitive treatmentMultivariable analysisNetwork guidelinesResults ProgramCell carcinomaTrial participationCancer DatabaseU.S. patients
1986
Prognostic indicators in diffuse large-cell (histiocytic) lymphoma
Todd M, Portlock C, Farber L, Holford T, Bertino J. Prognostic indicators in diffuse large-cell (histiocytic) lymphoma. International Journal Of Radiation Oncology • Biology • Physics 1986, 12: 593-601. PMID: 2422144, DOI: 10.1016/0360-3016(86)90068-4.Peer-Reviewed Original ResearchConceptsDiffuse large cell lymphomaLarge cell lymphomaPrognostic groupsSystemic symptomsPrognostic indicatorAnn Arbor staging systemBone marrow involvementBulk of diseaseLactic dehydrogenaseDiffuse histiocytic lymphomaAnn Arbor classificationStage of diseaseReliable prognostic indicatorChemotherapy clinical trialsLukes-Collins classificationSerum lactic dehydrogenaseMarrow involvementOverall survivalCombination chemotherapyPrognostic factorsDisease involvementPathological criteriaStaging systemSpecific therapyHistiocytic lymphoma
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply